Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Publication | Closed Access

DOI

1.2K

Citations

References

2013

Year

Stephen Chia, Tamas Hickish, V. Harvey, Alexandru Eniu, Roberto Hegg, Christoph Tausch, Jae Hong Seo, Y.-F. Tsai, Jayantha Ratnayake, Virginia McNally,

Annals of Oncology

Breast OncologyMedicineBreast CancerPharmacotherapyAnthracycline-free Chemotherapy RegimensCancer TreatmentOncologyRadiation Oncology